- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Pediatric Patients With Respiratory Diseases Need More Resources, Says Dr Debra Boyer
Debra Boyer, MD, pediatric pulmonologist at Nationwide Children’s Hospital and co-chair of the American Thoracic Society (ATS) International Conference Committee, highlights the need for more specialized care and research for children with respiratory diseases, who don't have access to the same therapies and testing as adults.
More innovation for children who have respiratory diseases in areas like testing, medication, and equipment are needed, said Debra Boyer, MD, pediatric pulmonologist at Nationwide Children’s Hospital and co-chair of the American Thoracic Society (ATS) International Conference Committee.
Transcript
What are some of the unique challenges for treating pediatric patients in the pulmonology field?
To me, one of the biggest areas is the fact that things are not done, tested, available as much in pediatrics as they are in adult medicine and adult respiratory diseases. Whether that's equipment, thinking about bronchoscopy use and interventions, there's just not enough of that equipment and things available to be able to do what we might want to do in pediatrics.
Similarly, a lot of medications are not approved in children that are available in adults. That also limits what kind of therapeutics we can do in pediatrics. So, it's an area that I think we all need to advocate for. We need to advocate for more testing and more availability, for all of those things for our pediatric patients.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
VBID, Heading Into a Third Decade, Looks to Promote Personalization and Access
March 12th 2025Speakers at the 2025 Value-Based Insurance Design summit recapped the accomplishments made over the past 20 years in designing insurance benefits with value in mind and looked ahead to iterations to come.
Read More
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Read More
